BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31481959)

  • 21. Concomitant diagnosis of immune deficiency and
    Sanford E; Farnaes L; Batalov S; Bainbridge M; Laubach S; Worthen HM; Tokita M; Kingsmore SF; Bradley J
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Genetic Study of X-linked Agammaglobulinemia Patients (The Benefit of Early Diagnosis).
    Alizadeh Z; Dashti P; Mazinani M; Nourizadeh M; Shakerian L; Tajik S; Movahedi M; Mamishi S; Pourpak Z; Fazlollahi MR
    Iran J Allergy Asthma Immunol; 2020 Jun; 19(3):305-309. PubMed ID: 32615664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel Bruton's tyrosine kinase gene (BTK) invariant splice site mutation in a Malaysian family with X-linked agammaglobulinemia.
    Chear CT; Gill HK; Ramly NH; Dhaliwal JS; Bujang N; Ripen AM; Mohamad SB
    Asian Pac J Allergy Immunol; 2013 Dec; 31(4):320-4. PubMed ID: 24383975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
    Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
    Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report.
    Li M; Chen W; Sun X; Wang Z; Zou X; Wei H; Wang Z; Chen W
    BMC Med Genet; 2019 Sep; 20(1):157. PubMed ID: 31510946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel BTK gene mutation creates a de-novo splice site in an X-linked agammaglobulinemia patient.
    Chear CT; Ripen AM; Mohamed SA; Dhaliwal JS
    Gene; 2015 Apr; 560(2):245-8. PubMed ID: 25680287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Widely divergent clinical phenotype of x-linked agammaglobulinemia in two cousins].
    Jansen AG; Noordzij JG; Bröcker-Vriends AH; van Dongen JJ; van Tol MJ; Bredius RG
    Ned Tijdschr Geneeskd; 2004 May; 148(21):1053-6. PubMed ID: 15185441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia.
    Toker O; Broides A; Lev A; Simon AJ; Megged O; Shamriz O; Tal Y; Somech R; Lee YN; Nahum A
    Immunol Res; 2022 Apr; 70(2):216-223. PubMed ID: 35001352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia.
    Martignani C; Massaro G; Bruno AG; Biffi M; Ziacchi M; Diemberger I
    Immunobiology; 2020 Jan; 225(1):151861. PubMed ID: 31740078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India.
    Rawat A; Jindal AK; Suri D; Vignesh P; Gupta A; Saikia B; Minz RW; Banday AZ; Tyagi R; Arora K; Joshi V; Mondal S; Shandilya JK; Sharma M; Desai M; Taur P; Pandrowala A; Gowri V; Sawant-Desai S; Gupta M; Dalvi AD; Madkaikar M; Aggarwal A; Raj R; Uppuluri R; Bhattad S; Jayaram A; Lashkari HP; Rajasekhar L; Munirathnam D; Kalra M; Shukla A; Saka R; Sharma R; Garg R; Imai K; Nonoyama S; Ohara O; Lee PP; Chan KW; Lau YL; Singh S
    Front Immunol; 2020; 11():612323. PubMed ID: 33584693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, immunological and genomic characteristics of children with X-linked agammaglobulinemia from Kerala, South India.
    Madathil Govindaraj G; Jain A; Edavazhippurath A; Bhoyar RC; Dhanasooraj D; Mishra A; Gupta V; Nair M; Shiny PM; Uppuluri R; Kumar A; Kashyap A; Ajith Kumar VT; Shankaran G; Senthivel V; Imran M; Kumar Divakar M; Sawant S; Dalvi A; Madkaikar M; Raj R; Sivasubbu S; Scaria V
    Hum Immunol; 2022 Apr; 83(4):335-345. PubMed ID: 35074268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations.
    Aadam Z; Kechout N; Barakat A; Chan KW; Ben-Ali M; Ben-Mustapha I; Zidi F; Ailal F; Attal N; Doudou F; Abbadi MC; Kaddache C; Smati L; Touri N; Chemli J; Gargah T; Brini I; Bakhchane A; Charoute H; Jeddane L; El Atiqi S; El Hafidi N; Hida M; Saile R; Alj HS; Boukari R; Bejaoui M; Najib J; Barbouche MR; Lau YL; Mellouli F; Bousfiha AA
    J Clin Immunol; 2016 Apr; 36(3):187-94. PubMed ID: 26931785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.
    Pérez de Diego R; López-Granados E; Rivera J; Ferreira A; Fontán G; Bravo J; García Rodríguez MC; Bolland S
    Clin Exp Immunol; 2008 Apr; 152(1):33-8. PubMed ID: 18241233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?
    Çekiç Ş; Özgür T; Karalı Y; Özkan T; Kılıç SŞ
    Turk J Pediatr; 2019; 61(6):937-940. PubMed ID: 32134589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA.
    Hernandez-Trujillo V; Zhou C; Scalchunes C; Ochs HD; Sullivan KE; Cunningham-Rundles C; Fuleihan RL; Bonilla FA; Petrovic A; Rawlings DJ; de la Morena MT
    J Clin Immunol; 2023 Aug; 43(6):1468-1477. PubMed ID: 37219739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of BTK mutations in male Algerian patterns with agammaglobulinemia and severe B cell lymphopenia.
    Boushaki S; Tahiat A; Meddour Y; Chan KW; Chaib S; Benhalla N; Smati L; Bensenouci A; Lau YL; Magdinier F; Djidjik R
    Clin Immunol; 2015 Dec; 161(2):286-90. PubMed ID: 26387629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential application of gene therapy to X-linked agammaglobulinemia.
    Moreau T; Calmels B; Barlogis V; Michel G; Tonnelle C; Chabannon C
    Curr Gene Ther; 2007 Aug; 7(4):284-94. PubMed ID: 17969561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
    Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
    Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mutation analysis and prenatal diagnosis in families of X-linked agammaglobulinemia caused by BTK gene mutation].
    Kong X; Mo G; Liu N; Tian P; Chen M
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1405-8. PubMed ID: 25142992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia.
    Kraft MT; Pyle R; Dong X; Hagan JB; Varga E; van Hee M; Boyce TG; Pozos TC; Yilmaz-Demirdag Y; Bahna SL; Abraham RS
    Clin Immunol; 2021 Aug; 229():108788. PubMed ID: 34182127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.